RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis | Journal of Biomedical Science | Full Text
Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of mortality in developing countries. Persistent infection with high-risk human papillomavirus (HPV) is a necessary cause for the development of cervical cancer. In addition, genetic and epigenetic alterations in host cell genes are crucial for progression of cervical precancerous lesions to invasive cancer. Although much progress has been made in understanding the life cycle of HPV and it’s role in the development of cervical cancer, there is still a critical need for accurate surveillance strategies and targeted therapeutic options to eradicate these cancers in patients. Given the widespread nature of HPV infection and the type specificity of currently available HPV vaccines, it is crucial that molecular details of the natural history of HPV infection as well as the biological activities of viral oncoproteins be elucidated. A better understanding of the mechanisms involved in oncogenesis can provide novel insights and opportunities for designing effective therapeutic approaches against HPV-associated malignancies. In this review, we briefly summarize epigenetic alterations and events that cause alterations in host genomes inducing cell cycle deregulation, aberrant proliferation and genomic instability contributing to tumorigenesis.
RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis Review Open access Published: 23 April 2019 Volume 26 , article number 28 ( 2019 ) Cite this article You have full access to this open access article Download PDF Save article View saved research Journal of Biomedical Science Aims and scope Submit manuscript RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis Download PDF Abstract Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of mortality in developing countries.
Explore this link on the map →related reading
- Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
- Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
- HPV and Cancer - NCIcancer.gov
- Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org
- HPV vaccine cutting cervical cancer by nearly 90%bbc.com
- Pancreatic Cancer - PMCncbi.nlm.nih.gov
- 人類乳突瘤病毒(Human papilloma virus; HPV) 與子宮頸癌的關係::台灣癌症基金會canceraway.org.tw
- Frontiers | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Updatefrontiersin.org
- p53 - Wikipediaen.wikipedia.org
- HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection - PMCncbi.nlm.nih.gov
- Targeting telomerase for cancer therapy | Oncogenenature.com
- Nasopharyngeal Carcinoma(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov